LexDanaLexDanabeta
Inventor

Timothy Harrison

Inventor
Great Dunmow, GB

Overview

68→
Patents
1995–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 68 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Dprimary
C07DHeterocyclic compounds38%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
A61KPreparations for medical, dental or toiletry purposes17%
C07CAcyclic or carbocyclic compounds6%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium3%
C07KPeptides1%
PatentTitleYear
11,053,213Pharmaceutical compounds20219,850,247Pyrimidopyrimidinones useful as Wee-1 kinase inhibitors20179,221,838'Inhibitors of AKT activity'20159,156,853'AKT inhibitor compounds for treatment of cancer'20158,546,376'Pharmaceutical compounds'20138,389,547'Piperidines and related compounds for the treatment of Alzheimer\'s disease'20138,362,075'Cyclohexyl sulphones for treatment of cancer'20138,242,103'Sulphamides for treatment of cancer'20127,728,022'(4, 5, 6, 7-tetrahydro-1-H-indol-7-yl) acetic acid derivatives for treatment of Alzheimer\'s disease'20107,598,386'Sulphones which modulate the action of gamma-secretase'20097,595,344'Sulphones which modulate the action of gamma secretase'20097,435,748'Gamma-secretase inhibitors'20087,427,621'Cyclic sulfamides for inhibition of gamma-secretase'20087,410,964'Cyclohexyl sulphones as gamma-secretase inhibitors'20087,411,004'Sulphones which modulate the action of gamma secretase'20087,371,771'Alkenyl-substituted spirocyclic sulfamides as inhibitors of gamma-secretase'20087,365,196'Sulphonamido-substituted bridged bicycloalkyl derivatives'20087,342,009'Cyclic sulfonamides for inhibition of gamma-secretase'20087,304,094'Cyclohexyl sulphones'20077,282,513'Heteroaryl substituted spirocyclic sulfamides for inhibition of gamma secretase'20077,205,434'Sulphonamides for control of beta-amyloid production'20077,183,303'Gamma-secretase inhibitors'20077,138,400'Sulfamides as gamma-secretase inhibitors'20067,105,509'Benzodiazepine derivatives as APP modulators'20067,101,895'Cyclohexyl sulphone derivatives as gamma-secretase inhibitors'20067,041,689'Heteroaryl substituted spriocyclic sulfamides for inhibition of gamma secretase'20066,984,663'Cyclohexyl sulphones'20066,890,956'Cyclohexyl sulphones as gamma-secretase inhibitors'20056,872,731'Imidazo-pyridine derivatives as ligands for GABA receptors'20056,828,322'Triazolo-pyridazine derivatives as ligands for GABA receptors'20046,756,511'Gamma-secretase inhibitors'20046,638,930'Morpholine and thiomorpholine tachykinin receptor antagonists'20036,613,765'Use of NK-1 receptor antagonists for treating major depressive disorders'20036,579,875'Triazolo-pyridazine derivatives as ligands for GABA receptors'20036,352,994'Substituted 1H-pyridinyl-2-ones as GABAA alpha 2/3 ligands'20026,319,924'Triazolo-pyridazine derivatives as ligands for GABA receptors'20016,303,605'Triazolo-pyridazine derivatives as ligands for GABA receptors'20016,291,460'Triazolo-pyridazine derivatives as ligands for GABA receptors'20016,271,230'Use of NK-1 receptor antagonists for treating cognitive disorders'20016,235,735'Morpholine and thiomorpholine tachykinin receptor antagonists'20016,200,982'Substituted 1H-pyridinyl-2-ones as GABAA-.alpha. 2/3 ligands'20016,133,255'Tricyclic pyridone analogues as GABA-A receptor ligands'20006,114,315'Use of NK-1 receptor antagonists for treating major depressive disorders with anxiety'20006,100,256'Use of NK-1 receptors antagonists for treating schizophrenic disorders'20006,096,729'Use of NK-1 receptor antagonists for treating amnestic disorders'20006,087,348'Use of NK-1 receptor antagonists for treating stress disorders'20006,071,927'Spiro-piperidine derivatives and their use as therapeutic agents'20006,071,909'Phenylbenzimidazole derivatives as ligands for GABA receptors'20006,060,469'Spiro-piperidine derivatives and their use as tachykinin antagonists'20006,048,859'Morpholine and thiomorpholine tachykinin receptor antagonists'20005,977,104'Use of NK-1 receptor antagonists for treating bipolar disorders'19995,952,315'Use of NK-1 receptor antagonists for treating bipolar disorders'19995,929,054'Use of NK-1 receptor antagonists for treating sexual dysfunctions'19995,925,627'Use of NK-1 receptor antagonists for treating movement disorders'19995,922,744'Ethane-1-2-diamine derivatives and tachykinin antagonists'19995,919,781'Use of NK-1 receptor antogonists for treating substance use disorders'19995,880,123'Hemolysis prevention by non-ionic surfactants'19995,872,116'Morpholine and thiomorpholine tachykinin receptor antagonists'19995,824,678'Morpholine derivatives and their use as therapeutic agents'19985,807,865'3,3-disubstituted piperidine derivatives and their use as therapeutic agents'19985,756,127'Implantable bioresorbable string of calcium sulfate beads'19985,728,695'Spiroketal derivatives, compositions containing them and their use as therapeutic agents'19985,719,149'Morpholine derivatives and their use as therapeutic agents'19985,719,147'Morpholine and thiomorpholine tachykinin receptor antagonists'19985,637,699'Process for preparing morpholine tachykinin receptor antagonists'19975,620,989'4-Arylmethyloxymethyl piperidines as tachykinin antagonsits'19975,612,337'Substituted morpholine derivatives and their use as therapeutic agents'19975,459,270'Azacyclic compounds, processes for their preparation and pharmaceutical compositions containing them'1995

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1995–2013Patents assigned to MERCK SHARP & DOHME (53)· patent assignee history
1995–2010Based in Great Dunmow, GB· patent location history
1997–2003Patents assigned to MERCK & CO INC (6)· patent assignee history
1998Based in Cambridge, GB· patent location history
1998Based in Memphis, TN, US· patent location history
2012–2015Patents assigned to HARRISON TIMOTHY (5)· patent assignee history
2012–2013Based in Belfast, IE· patent location history
2013–2021Patents assigned to ALMAC DISCOVERY LTD (5)· patent assignee history
2013–2015Patents assigned to BURKAMP FRANK (2)· patent assignee history
2013–2021Based in Craigavon, GB· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK SHARP & DOHME531995–2013
MERCK & CO INC61997–2003
ALMAC DISCOVERY LTD52013–2021
HARRISON TIMOTHYself52012–2015
BURKAMP FRANK22013–2015
Locations
LocationPatentsSpan
Great Dunmow, GB581995–2010
Craigavon, GB52013–2021
Belfast, IE32012–2013
Cambridge, GB11998
Memphis, TN, US11998